Dasatinib polymorphs and their preparation process

• 收藏
• 分享

专利权人:

Teva Pharmaceutical Industries Ltd.

发明人:

Simo, Ondrej,Gabriel, Roman,Filipcik, Jiri,Martaus, Alexandr,Jegorov, Alexandr,Gavenda, Ales,Aronhime, Judith,Vraspir, Pavel,Koltai, Tamas,Faustmann, Jiri

申请号：

ES11194987

公开号：

ES2565521T3

申请日:

2008.10.23

申请国别(地区):

ES

年份:

2016

代理人:

摘要：

Anhydrous form of dasatinib characterized by a PXRD pattern that has any of 5 peaks selected from the list consisting of: 7.2, 11.9, 14.4, 16.5, 17.3, 19.1, 20, 8, 22.4, 23.8, 25.3 and 29.1 ± 0.2 degrees 2-theta.Forma anhidra de dasatinib caracterizada por un patrón de PXRD que tiene cualquiera de 5 picos seleccionados de la lista que consiste en: 7,2, 11,9, 14,4, 16,5, 17,3, 19,1, 20,8, 22,4, 23,8, 25,3 y 29,1 ± 0,2 grados 2-theta.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/